Daniel C. Adelman
Overview
Daniel C. Adelman received an average of $2M in total compensation, including $375K in salary, at Aimmune Therapeutics from 2016 to 2019. Daniel Adelman also received $521K at Sunesis Pharmaceuticals in 2006.
Source: SEC filings on April 9, 2020, April 10, 2019, April 11, 2018, and April 27, 2007.
Related executives
We found 22 more executives who work or worked at Aimmune Therapeutics and Sunesis Pharmaceuticals.
Ivor Royston
Sunesis Pharmaceuticals
Chief Executive Officer
Lisa Rojkjaer
Sunesis Pharmaceuticals
Chief Medical Officer
Daniel Chevallard
Sunesis Pharmaceuticals
Chief Financial Officer
Par Hyare
Sunesis Pharmaceuticals
Chief Executive Officer
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics